What endpoints should be used for clinical studies in acute kidney injury?

Intensive Care Medicine

Volumn 43, Issue 6, 2017, Pages 901-903

  Kellum, John A ^a   Zarbock, Alexander ^b   Nadim, Mitra K ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ACUTE KIDNEY FAILURE; ARTICLE; CLINICAL OUTCOME; CLINICAL STUDY; HUMAN; REGISTER; TREATMENT OUTCOME; BIOASSAY; BLOOD; DISEASE EXACERBATION; MORTALITY; QUALITY OF LIFE; RISK FACTOR; URINE;

ACUTE KIDNEY INJURY; BIOMARKERS; CLINICAL STUDIES AS TOPIC; DISEASE PROGRESSION; ENDPOINT DETERMINATION; HUMANS; QUALITY OF LIFE; REGISTRIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 85014064538     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-017-4732-1     Document Type: Article

References (10)

1. KDIGO AKI Workgorup (2012) Kidney disease: improving global outcomes (KDIGO) clinical practice guideline for acute kidney injury. Kidney Int 2:1–141
2. Kellum JA, Sileanu FE, Murugan R et al (2015) Classifying AKI by urine output versus serum creatinine level. J Am Soc Nephrol 26:2231–2238. doi:10.1681/ASN.2014070724
3. Kaddourah A, Basu RK, Bagshaw SM et al (2016) Epidemiology of acute kidney injury in critically ill children and young adults. N Engl J Med. doi:10.1056/NEJMoa1611391
4. Liu KD, Vijayan A, Rosner MH et al (2016) Clinical adjudication in acute kidney injury studies: findings from the pivotal TIMP-2*IGFBP7 biomarker study. Nephrol Dial Transpl. doi:10.1093/ndt/gfw238
5. Fuhrman DY, Kellum JA (2016) Biomarkers for diagnosis, prognosis and intervention in acute kidney injury. Contrib Nephrol 187:47–54. doi:10.1159/000442364
6. Kashani K, Al-Khafaji A, Ardiles T et al (2013) Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 17:R25. doi:10.1186/cc12503
7. Koyner JL, Shaw AD, Chawla LS et al (2015) Tissue inhibitor metalloproteinase-2 (TIMP-2) IGF-binding protein-7 (IGFBP7) levels are associated with adverse long-term outcomes in patients with AKI. J Am Soc Nephrol 26:1747–1754. doi:10.1681/ASN.2014060556
8. Kellum JA, Sileanu FE, Bihorac A et al (2016) Recovery after acute kidney injury. Am J Respir Crit Care Med. doi:10.1164/rccm.201604-0799OC
9. Chawla LS, Eggers PW, Star RA, Kimmel PL (2014) Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med 371:58–66. doi:10.1056/NEJMra1214243
10. James MT, Dixon E, Roberts DJ et al (2014) Improving prevention, early recognition and management of acute kidney injury after major surgery: results of a planning meeting with multidisciplinary stakeholders. Can J Kidney Health Dis 1:20. doi:10.1186/s40697-014-0020-y